Buprenorphine Dosing Interval - 5 - Contacts and Locations

Home

Buprenorphine Dosing Interval - 5

This study has been completed.

Study NCT00000209. Last updated on August 16, 2005. Information provided by National Institute on Drug Abuse (NIDA)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000209

Locations


United States, California
	Friends Research Institute
	Los Angeles, California, United States, 90025

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

Investigators


Principal Investigator:	Walter Ling, M.D.	Friends Research Institute, Inc.